Cargando…

LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes

AIMS/HYPOTHESIS: Diabetic cardiomyopathy is a myocardial disease triggered by impaired insulin signalling, increased fatty acid uptake and diminished glucose utilisation. Liver X receptors (LXRs) are key transcriptional regulators of metabolic homeostasis. However, their effect in the diabetic heart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannon, Megan V., Silljé, Herman H. W., Sijbesma, Jürgen W. A., Khan, Mohsin A. F., Steffensen, Knut R., van Gilst, Wiek H., de Boer, Rudolf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742491/ https://www.ncbi.nlm.nih.gov/pubmed/26684450 http://dx.doi.org/10.1007/s00125-015-3827-x

Ejemplares similares

Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
por: Cannon, Megan V, et al.
Publicado: (2015)

Regulation of the (pro)renin–renin receptor in cardiac remodelling
por: Mahmud, Hasan, et al.
Publicado: (2012)

AKIP1, a Cardiac Hypertrophy Induced Protein that Stimulates Cardiomyocyte Growth via the Akt Pathway
por: Yu, Hongjuan, et al.
Publicado: (2013)

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
por: Yin, Meimei, et al.
Publicado: (2011)

Emerging role of liver X receptors in cardiac pathophysiology and heart failure
por: Cannon, Megan V., et al.
Publicado: (2015)

The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro
por: Lu, Bo, et al.
Publicado: (2010)

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin
por: Ruifrok, Willem-Peter T., et al.
Publicado: (2010)

AKIP1 Expression Modulates Mitochondrial Function in Rat Neonatal Cardiomyocytes
por: Yu, Hongjuan, et al.
Publicado: (2013)

From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
por: Suthahar, Navin, et al.
Publicado: (2017)

Cardiac Function and Architecture Are Maintained in a Model of Cardiorestricted Overexpression of the Prorenin-Renin Receptor
por: Mahmud, Hasan, et al.
Publicado: (2014)

RNA binding Motif protein-38 regulates myocardial hypertrophy in LXR-α-dependent lipogenesis pathway
por: Li, Yao, et al.
Publicado: (2021)

Telomere biology in healthy aging and disease
por: Oeseburg, Hisko, et al.
Publicado: (2009)

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014)

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling
por: Nijholt, Kirsten T., et al.
Publicado: (2023)

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
por: Yurista, Salva R., et al.
Publicado: (2020)

Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance
por: Pozder, Carolin, et al.
Publicado: (2023)

Animal models of cardiorenal syndrome: a review
por: Szymanski, Mariusz K., et al.
Publicado: (2011)

The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise
por: Nijholt, Kirsten T., et al.
Publicado: (2021)

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020)

Susceptibility of Pancreatic Beta Cells to Fatty Acids Is Regulated by LXR/PPARα-Dependent Stearoyl-Coenzyme A Desaturase
por: Hellemans, Karine H., et al.
Publicado: (2009)

Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion
por: Hartman, Minke H. T., et al.
Publicado: (2016)

The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms
por: Pourcet, Benoit, et al.
Publicado: (2016)

Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload
por: De Jong, Anne Margreet, et al.
Publicado: (2013)

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies
por: Stege, Nienke M., et al.
Publicado: (2021)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis
por: Feng, Ke, et al.
Publicado: (2021)

Cyclical stretch induces structural changes in atrial myocytes
por: De Jong, Anne Margreet, et al.
Publicado: (2013)

LXRα and LXRβ Nuclear Receptors Evolved in the Common Ancestor of Gnathostomes
por: Fonseca, Elza, et al.
Publicado: (2017)

Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease
por: Becares, Natalia, et al.
Publicado: (2019)

Effects of Sodium–Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)

A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study
por: Asselbergs, Folkert W, et al.
Publicado: (2006)

Nuclear Hormone Receptor LXRα Inhibits Adipocyte Differentiation of Mesenchymal Stem Cells with Wnt/beta-catenin Signaling
por: Matsushita, Kenichi, et al.
Publicado: (2015)

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population
por: Piek, Arnold, et al.
Publicado: (2021)

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
por: Suthahar, Navin, et al.
Publicado: (2018)

Insights From Liver‐Humanized Mice on Cholesterol Lipoprotein Metabolism and LXR‐Agonist Pharmacodynamics in Humans
por: Minniti, Mirko E., et al.
Publicado: (2020)

Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches
por: Chen, Meimei, et al.
Publicado: (2018)

miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages
por: Vinod, Manjula, et al.
Publicado: (2014)

ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ
por: Pavez-Giani, Mario G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qr02c51tka2cek8g9rfu65g3ju